SCHEMBL12428243

SCHEMBL12428243

CCCCCCCCN1CCCc2cc(-c3ccc(/C=C4\C(=O)N(c5ccccc5)N=C4C(=O)O)s3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRF1 P14222 6/20 0.37
EP300 Q09472 2/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MEN1 O00255 5/20 0.35
ALDH1A1 P00352 5/20 0.35
MAPT P10636 5/20 0.35
KMT2A Q03164 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
SMAD3 P84022 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACHE P22303 2/20 0.35
PPARG P37231 1/20 0.35
HPGD P15428 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428242 0.89 EP300 (0.37) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428438 0.87 PRF1 (0.39) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428450 0.86 KMT2A (0.39) MEN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL12428249 0.83 EP300 (0.41) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428264 0.82 EP300 (0.40) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428261 0.82 EP300 (0.40) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428387 0.81 ACHE (0.32) MEN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL12428397 0.81 ALDH1A1 (0.36) PRF1EP300HDAC6MEN1ALDH1A1
SCHEMBL12428485 0.81 KMT2A (0.42) MEN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL12428451 0.81 SCN9A (0.38) EP300HDAC6MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 PRF1 3412/4885EP300 2442/4885HDAC6 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.